ReviewAdvances in therapy2017

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin.

Akira Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.